Value-based care for payers and providers
Experts explore how value-based care is changing global healthcare, from pricing strategies and insurer-provider partnerships to the growing role of data and technology
The transition to value-based care is evolving. Unlike traditional models that prioritise service volume, value-based care emphasises the quality of care delivered and the outcomes achieved, taking into account the overall cost to the system.
Defining value in healthcare
James Walker, International Network Director at Charles Taylor Assistance, emphasised that defining value in healthcare services largely depends on perspective.
“An international private medical insurance (IPMI) insurer may look at it very differently to a travel insurer,” he stated. “In the IPMI world, where treatment is elective and procedures planned and steered into a controlled network, value would be the quality of healthcare weighted with the price, successful outcomes and ultimately customer satisfaction from the network you are directing your members into for their healthcare needs.”
Walker pointed out that for a travel insurer, the concept of value differs significantly, as it is primarily assessed by the quality and efficiency of emergency healthcare and the ability to ensure the patient’s safe repatriation.
“Ultimately, providers’ value should be defined as quality healthcare outcomes for their patients, although some may be more interested in maximising revenue from patients,” he added.
María Cecilia Aponte Caicedo, Regional Head of International Care and Wellness Programme at Hospiten, noted: “For me, value in patient care is the balance between the quality of healthcare outcomes achieved and the cost incurred to deliver those outcomes. In a value-based care model, the focus shifts from the volume of services provided to the effectiveness of care in improving patients’ health.
“Value is created when patients receive timely, effective, and personalised treatments that lead to better health outcomes, improved patient satisfaction, and efficient resource utilisation.”
Eve Jokel, International Patient Services Director at Luz Saúde, shared a similar opinion, defining value as achieving the best clinical and patient outcomes with the most efficient use of resources. “Determining the value requires researching and adapting clinical protocols, knowing the costs of all parts of the pathway, looking at the clinical impact of each step, and receiving feedback from the patients from the moment of diagnosis through to recovery and for a period of time afterwards, depending on the pathology,” she explained.
Wesley Wolfe, Vice President of Market Network Services at Cleveland Clinic, noted that Cleveland Clinic’s value-based care models are generally longitudinal, with a focus on long-term outcomes such as cancer screenings and the management of chronic conditions like COPD, and often incorporate elements of cost and trend mitigation.
Challenges in shifting to value-based care models
Aponte Caicedo pointed out that transitioning to a value-based care model presents several challenges for healthcare providers working with insurers and public systems, particularly concerning financial risk, data integration, care coordination, regulatory complexity, and resistance to change from stakeholders.
Jokel explained that a variety of performance-based payment models exist, some of which have been implemented for many years. She noted that bundled payments are already well established in Portugal, covering both outpatient services (such as emergency visits and consultation packages) and inpatient procedures (including surgical packages).
However, she emphasised that performance-based contracts – where compensation is tied to improvements in outcomes or cost savings – are more complex to implement. These models require consensus on which performance indicators to track and how to translate those metrics into fair financial incentives.
“The main challenge lies largely in reaching a consensus on
which indicators and results should be achieved for each pathology, how and who measures these indicators, which benchmarks should be achieved and how to distribute compensation between payer and provider,” she stated.
Jokel also stressed that developing value-based pricing models demands significant time and resources, including outcome tracking systems, full care pathway cost analysis, and dedicated infrastructure.
She added that insurers can support value-based care by aligning key performance indicators (KPIs), understanding established care pathways, and creating shared incentive structures that reward improved outcomes and cost control on both sides.
Ultimately, providers’ value should be defined as quality healthcare outcomes for their patients, although some may be more interested in maximising revenue from patients
Ensuring fair and transparent pricing for patients and payers
Aponte Caicedo explained that hospitals and healthcare systems can ensure fair and transparent pricing by adopting standardised pricing frameworks, clear communication strategies, and data-driven models aligned with regional market conditions and cost structures. She outlined several key strategies:
• Benchmark-based pricing that accounts for regional cost differences
• Bundled pricing to cover entire treatment episodes
• Cost-plus pricing to reflect direct costs, overheads, and fair margins
• Clear, upfront cost estimates with itemised breakdowns
• Patient financial counselling for cost navigation and insurance support
• Collaboration with payers and regulators
• Leveraging technology and data analytics.
Peter Nardi, Senior Contract Manager for International Markets at Cleveland Clinic, explained that the US Hospital Price Transparency Final Rule (2021) requires hospitals to publish machine-readable chargemasters listing all billable items and services, as well as a consumer-friendly list of at least 300 shoppable services. “This allows consumers to compare prices for common procedures across different providers and locations, which is especially important for self-pay patients who are travelling to the US for medical care,” he said.
“Recent changes to this law have created stricter requirements that, if followed by US hospitals, should offer a greater degree of transparency to patients and payers,” he continued. The recent updates include disclosing the type of reimbursement (e.g. case rate, percentage discount) for each item. “As more hospitals implement these required changes, patients, insurers, and third-party administrators will be able to prepare for upcoming medical treatment and better manage their exposure,” he concluded.
Do direct contracts with insurers or employers help to reduce costs?
Jokel emphasised that direct contracts between insurers and providers help manage costs by eliminating intermediaries, aligning operations, and enabling tailored care strategies. She explained that these agreements support cost-saving incentives, preventative care, and chronic disease management by focusing on long-term outcomes rather than individual interventions. “A direct relationship supports knowledge of how each conducts its activities and provides an opportunity to align, remove barriers to care, and work together to assure an efficient provision of care and support to patients,” she said.
Jokel noted that direct contracts also enable custom benefits for patient groups and streamline administrative processes, like authorisations. Providers benefit from better policy knowledge and closer collaboration with insurers.
Nardi added that direct agreements
can be effective in lowering costs for insurance companies by eliminating access fees and reducing issues like
claim errors and network disputes, which often arise when providers don’t recognise the network. Such contracts also give insurers greater oversight of claims, benefits, and patient access, helping ensure smoother, cashless service when coverage is verified.
However, he emphasised that payers must have robust systems and staffing in place to support this model. “From a front-end perspective, payers would need to have 24/7 capabilities, as well as case managers and nurses to assist with benefit and medical review issues; in other words, staffing and systems become a consideration.”
Transitioning to a value-based care model presents several challenges for healthcare providers working with insurers and public systems
Walker agreed that from an insurer’s perspective, having pre-agreed contracts is very helpful in controlling costs. “The ability
to negotiate a price list and a suitable discount, and a code of conduct prior to any treatment means, to a certain extent, you know the likely costs and value of the healthcare services that will be provided,” he said.
However, he noted that sometimes third-party or network contracts are just as effective. “The key is to understand what you can achieve directly versus using a third party, and then making an informed decision on what route will drive the best-value healthcare services.”
Improving reimbursement and payment processes
Aponte Caicedo explained that improving reimbursement and payment systems was key to ensuring financial stability, reducing administrative burden, and enhancing patient care. She outlined several strategies, including standardising and automating billing using artificial intelligence (AI) and electronic claims; enhancing transparency and communication through upfront cost estimates and real-time digital updates; streamlining authorisation by leveraging predictive analytics and shared data; and fostering closer collaboration between payers and providers to regularly review and optimise reimbursement policies.
Recent changes to the law have created stricter requirements that, if followed by US hospitals, should offer a greater degree of transparency to patients and payers
Wolfe added that timely, accurate data sharing was essential for effective care delivery and smooth payment processes. He emphasised the importance of knowing which patients are covered under which care models and being aware of any care delivered outside those systems, as this can affect ongoing treatment.
“Sharing of timely, accurate data improves the care delivered to patients, speeds reimbursement and payment processes, and reduces the amount of time spent reconciling payments on the back end of the process,” he concluded.
Nardi highlighted the role of guarantee of payment (GOP) letters in helping providers understand benefit limits, exclusions, and patient financial responsibilities. Having this information in advance, he noted, enables faster appointment scheduling and smoother financial clearance.
He also stressed that both providers and payers must fulfil their responsibilities: providers must submit timely, accurate claims, and payers must meet payment obligations to avoid delays and support collaboration. “Doing so will provide more time and opportunity for both sides to collaborate on enhancements to patient experience, process, and business development,” he concluded.
Managing provider relationships across borders
Walker explained that proactively managing provider relationships requires in-house or trusted third-party expertise, including network, cost containment, and medical teams. Combining direct relationships with those of local agents helps navigate cultural differences, such as in Japan, where providers only work through in-country agents. Medical expertise is also key to effective communication with provider medical staff.
“By having medical expertise available when managing live cases, you can communicate efficiently with provider medical staff, without the barriers seen when non-medical staff try to discuss cases or treatment with medical staff,” he stated.
Regional challenges
Walker noted that while customers can generally access good healthcare worldwide, regions with limited medical infrastructure, remote locations, weak public health systems, or high tourist volumes can present challenges to delivering good-value care. He explained that these regions typically share factors such as limited medical supply, seasonal service demand, competition among private providers targeting tourists, international debt collection challenges, or efforts to rebrand public healthcare as private.
“There are many locations, especially around tourist hotspots, where doctors, hospitals and clinics take advantage of international travellers to inflate prices or overtreat patients and reduce the value of the healthcare services they provide,” he said. “These sorts of behaviours that drive questionable value are not restricted to certain countries or locations; they could be anywhere in the world, irrespective of how developed or governed a healthcare system may be.”
Discussing pricing in regions without standard models, Walker emphasised the importance of negotiating prices before treatment when possible, but said it’s not always essential. “It’s more important to know the actual cost of providing healthcare services in the region. This way, regardless of whether or not you have a pre-negotiated deal with a provider, you are able to understand the cost of providing healthcare services in the region and negotiate after the event if you have not been able to do so beforehand.”
There are many locations, especially around tourist hotspots, where doctors, hospitals and clinics take advantage of international travellers
Role of technology in improving value-based care
Walker highlighted that in the travel insurance world, technology has driven market growth and change by expanding outpatient services, such as self-service portals that give customers access to vetted medical care at controlled prices. “This is certainly bringing value to what was in the past an area which did not always show great value for the healthcare services provided,” he stated.
Aponte Caicedo outlined three major innovations that are enhancing pricing transparency and operational efficiency. AI-powered tools like ClearHealthCosts and GoodRx enable patients to compare treatment costs across providers, supporting more informed healthcare decisions. She also highlighted blockchain technology as a secure way for hospitals, insurers, and regulators to share real-time pricing data, improving consistency and reducing discrepancies. Additionally, robotic process automation (RPA) is streamlining administrative processes.
Looking ahead, Nardi pointed to promising advancements still under development. “Real-time or near-real-time data exchange with a payer regarding patient eligibility and benefit status is one of the most exciting developments on the technology front right now. As data sets continue to grow, there should be a large potential to better predict disease progression and therefore deploy interventions to mitigate that progression. Sadly, that technology is not quite ready for prime time just yet.”
Conclusion
Value-based care is becoming a central focus in global healthcare. While approaches vary by region and care model, the goals remain consistent: improving patient outcomes, ensuring fair pricing, and making care delivery more efficient. Continued collaboration between insurers, providers, and regulators, supported by better data sharing and digital tools, will be essential to making value-based models successful in diverse settings.
August 2025
Issue
This month we look at the rising demand for medical escorts on commercial airlines, plus ask how the latest technology can help insurance companies. In our International Hospitals and Healthcare Review we examine humanising IPMI in the digital age, and ask what makes a destination desirable for medical tourism.
Alysia Cameron-Davies
Alysia is a copy writer for Voyageur Publishing.
February 2025
Issue
Offering readers a deep dive into the issues facing providers and payers of healthcare services around the world. Cost containment, international patient department development, the role of AI in healthcare delivery and more.